The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.
NCT00171470
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyspepsia
Interventions
DRUG:
Tegaserod
Sponsor
Novartis